Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 28 results.
User Information
Export Records
  1. 1.   In pursuit of sensitivity: Lessons learned from viral nucleic acid detection and quantification on the raindance ddPCR platform
  2. Long, Samuel
  3. Methods. 2021, Apr 9; 201: 82-95.
  1. 2.   Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential
  2. O'Brien, Thomas R; Young,Howard; Donnelly, Raymond P; Prokunina-Olsson, Ludmila
  3. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 2019, OCT 1; 39(10): 586-591.
  1. 3.   Human monoclonal antibodies as candidate therapeutics against emerging viruses
  2. Jin, Yujia; Lei, Cheng; Hu, Dan; Dimitrov, Dimiter S; Ying, Tianlei
  3. Frontiers of medicine. 2017, Nov 20;
  1. 4.   Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance
  2. An, P.; Thio, C. L.; Kirk, G. D.; Donfield, S.; Goedert, J. J.; Winkler, C. A.
  3. Journal of Infectious Diseases. 2008 198(8): 1159-1165.
  1. 5.   Human herpesvirus 8 seroprevalence among children and adolescents in the United States
  2. Anderson, L. A.; Li, Y.; Graubard, B. I.; Whitby, D.; Mbisa, G.; Tan, S.; Goedert, J. J.; Engels, E. A.
  3. Pediatric Infectious Disease Journal. 2008 27(7): 661-664.
  1. 6.   Structural basis for K65R function: tenofovir resistance, reduced nucleotide incorporation and excision antagonism
  2. Das, K.; Bandwar, R.; White, K. L.; Feng, J. Y.; Sarafianos, S. G.; Tuske, S.; Tu, X.; Clark, A. D.; Boyer, P. L.; Gaffney, B. L.; Jones, R. A.; Miller, M. D.; Hughes, S. H.; Arnold, E.
  3. Antiviral Therapy. 2008 13(4): A44-A44.
  1. 7.   Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy
  2. Hare, C. B.; Mellors, J.; Krambrink, A.; Su, Z. H.; Skiest, D.; Margolis, D. M.; Patel, S. S.; Barnas, D.; Frenkel, L.; Coombs, R. W.; Aweeka, F.; Morse, G. D.; Haas, D. W.; Boltz, V.; Palmer, S.; Coffin, J.; Havlir, D. V.
  3. Clinical Infectious Diseases. 2008 47(3): 421-424.
  1. 8.   Effects of delays in peripheral blood processing, including cryopreservation, on detection of CD31 expression on naive CD4 T cells
  2. Higgins, J.; Metcalf, J. A.; Stevens, R. A.; Baseler, M.; Proschan, M.; Lane, H. C.; Sereti, I.
  3. Clinical and Vaccine Immunology. 2008 15(7): 1141-1143.
  1. 9.   The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: Implications for echinocandin therapy in neonates
  2. Hope, W. W.; Mickiene, D.; Petraitis, V.; Petraitiene, R.; Kelaher, A. M.; Hughes, J. E.; Cotton, M. P.; Bacher, J.; Keirns, J. J.; Buell, D.; Heresi, G.; Benjamin, D. K.; Groll, A. H.; Drusano, G. L.; Walsh, T. J.
  3. Journal of Infectious Diseases. 2008 197(1): 163-171.
  1. 10.   Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodies
  2. Kemp, T. J.; Hildesheim, A.; Falk, R. T.; Schiller, J. T.; Lowy, D. R.; Rodriguez, A. C.; Pinto, L. A.
  3. Clinical and Vaccine Immunology. 2008 15(1): 60-64.
  1. 11.   Herniated nuclear morphology and cytoskeletal anomalies in neutrophils from sisters with recurrent infections
  2. Kuhns, D.; Vinh, D.; Uzel, G.; Gallin, J.; Holland, S.
  3. International Journal of Infectious Diseases. 2008 12: 13-.
  1. 12.   Variation in the major surface glycoprotein genes in Pneumocystis jirovecii
  2. Kutty, G.; Maldarelli, F.; Achaz, G.; Kovacs, J. A.
  3. Journal of Infectious Diseases. 2008 198(5): 741-749.
  1. 13.   Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1
  2. Mackelprang, R. D.; John-Stewart, G.; Carrington, M.; Richardson, B.; Rowland-Jones, S.; Gao, X.; Mbori-Ngacha, D.; Mabuka, J.; Lohman-Payne, B.; Farquhar, C.
  3. Journal of Infectious Diseases. 2008 197(8): 1156-1161.
  1. 14.   Seroprevalence and risk factors for human herpesvirus 8 infection, rural egypt
  2. Mbulaiteye, S. M.; Pfeiffer, R. M.; Dolan, B.; Tsang, V.; Noh, J.; Mikhail, N.; Abdel-Hamid, M.; Hashem, M.; Whitby, D.; Strickl, G. T.; Goedert, J. J.
  3. Emerging Infectious Diseases. 2008 14(4): 586-591.
  1. 15.   Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV
  2. Mizukoshi, E.; Eisenbach, C.; Edlin, B. R.; Newton, K. P.; Raghuraman, S.; Weiler-Normann, C.; Tobler, L. H.; Busch, M. P.; Carrington, M.; McKeating, J. A.; O'Brien, T. R.; Rehermann, B.
  3. Journal of Infectious Diseases. 2008 198(2): 203-212.
  1. 16.   HIV-1 reverse transcriptase connection domain mutations reduce template RNA degradation and enhance nucleoside reverse transcriptase inhibitor excision
  2. Nikolenko, G. N.; Delviks-Frankenberry, K. A.; Boyer, P. L.; Hughes, S. H.; Coffin, J. M.; Jere, A.; Pathak, V. K.
  3. Antiviral Therapy. 2008 13(4): A60-A60.
  1. 17.   Mutations in the reverse transcriptase connection and RNase H domains exhibit dual resistance to nucleoside and non-nucleoside reverse transcriptase inhibitors
  2. Nikolenko, G. N.; Delviks-Frankenberry, K. A.; Jere, A.; Pathak, V. K.
  3. Antiviral Therapy. 2008 13(4): A55-A55.
  1. 18.   The fidelity of HIV-1 reverse transcription: reverse transcriptase variants with altered mutation levels during replication
  2. Nissley, D. V.; Shenk, J. L.; Ambrose, Z.; Strathern, J. N.; Sluis-Cremer, N.
  3. Antiviral Therapy. 2008 13(4): A61-A61.
  1. 19.   Single cell analysis of HIV DNA from infected patients
  2. Palmer, S.; Maldarelli, F.; Kearney, M.; Shao, W.; Rock, D.; Mellors, J.; Albert, J.; Coffin, J.
  3. Antiviral Therapy. 2008 13(4): A75-A75.
  1. 20.   Species-dependent differences in virulence of medically important zygomycetes in neutropenic hosts are related to sporangiospore germination, hyphal metabolism, and circulating molecular biomarker levels
  2. Petraitiene, R.; Petraitis, V.; Antachopoutos, C.; Hughes, J. E.; Cotton, M. P.; Harrington, S. M.; Kasai, M.; Francesconi, A.; Beveridge, M. G.; Sein, T.; Schaufele, R. L.; Bacher, J.; Kontoyiannis, D. P.; Walsh, T. J.
  3. International Journal of Infectious Diseases. 2008 12: S49-S49.
  1. 21.   CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients
  2. Read, S. W.; Lempicki, R. A.; Di Mascio, M.; Srinivasula, S.; Burke, R.; Sachau, W.; Bosche, M.; Adelsberger, J. W.; Sereti, I.; Davey, R. T.; Tavel, J. A.; Huang, C. Y.; Issaq, H. J.; Fox, S. D.; Lane, H. C.; Kovacs, J. A.
  3. Journal of Infectious Diseases. 2008 198(6): 843-850.
  1. 22.   Role of Gag polymorphisms in HIV-1 sensitivity to the maturation inhibitor bevirimat
  2. Salzwedel, K.; Reddick, M.; Matall, C.; Finnegan, C.; Adamson, C.; Sakalian, M.; Stanley, D.; Martin, D.; McCallister, S.; Freed, E.; Allaway, G.
  3. Antiviral Therapy. 2008 13(4): A31-A31.
  1. 23.   Nucleoside analogues targeted against nucleoside reverse transcriptase inhibitor-resistant HIV-1 reverse transcriptase
  2. Vu, B.; Boyer, P. L.; Siddiqui, M. A.; Ambrose, Z.; Marquez, V.; Hughes, S. H.
  3. Antiviral Therapy. 2008 13(4): A37-A37.
  1. 24.   A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population
  2. Zeng, Z.; Guan, L.; An, P.; Sun, S.; O'Brien, S. J.; Winkler, C. A.; Consortium, C. H. S.
  3. BMC Infectious Diseases. 2008 8(1): 1-9.
  1. 25.   Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody
  2. Zhu, Z.; Bossart, K. N.; Bishop, K. A.; Crameri, G.; Dimitrov, A. S.; McEachern, J. A.; Feng, Y.; Middleton, D.; Wang, L. F.; Broder, C. C.; Dimitrov, D. S.
  3. Journal of Infectious Diseases. 2008 197(6): 846-853.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel